Diazepam
Medication for anxiety, seizures, and muscle spasms
| Diazepam | |
|---|---|
| Trade names | Valium, others
|
| Chemical nomenclature | |
| IUPAC name | 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
|
| Pharmacology | |
| Drug class | Benzodiazepine |
| Routes | oral, intramuscular, intravenous, rectal, nasal, buccal film
|
| Bioavailability | 76% (64–97%) oral, 81% (62–98%) rectal |
| Metabolism | Liver – CYP2B6 (minor route) to desmethyldiazepam, CYP2C19 (major route) to inactive metabolites, CYP3A4 (major route) to temazepam
|
| Excretion | Kidney |
| Legal status | Rx-only |
| Identifiers | |
| CAS Number | 439-14-5 |
| PubChem | 3016 |
| DrugBank | DB00829 |
| ChemSpider | 2908 |
| UNII | Q3JTX2Q7TU |
| KEGG | D00293 |
| ChEMBL | 12 |
| Chemical data
| |
| Chemical formula | C16H13N2O1Cl1
|



Diazepam is a widely used benzodiazepine medication, primarily prescribed as a sedative, anxiolytic, muscle relaxant, and anticonvulsant for treating acute seizures or status epilepticus. It is available in both oral and intravenous forms, with distinct clinical applications. Oral diazepam is commonly used for managing anxiety disorders, while intravenous diazepam is reserved for emergency anticonvulsant therapy. Although generally well-tolerated, diazepam carries potential risks of dependency and withdrawal and must be used under medical supervision. Rare instances of cholestatic liver injury have been reported with oral use, but intravenous administration is not linked to liver injury.
Mechanism of Action and Pharmacology[edit]
Diazepam exerts its effects by enhancing the activity of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system (CNS). By binding to GABA_A receptors, diazepam increases GABA-mediated synaptic transmission and induces its sedative, anxiolytic, anticonvulsant, and muscle-relaxing properties.
Anticonvulsant Effects[edit]
Diazepam's antiseizure effects are particularly valuable in managing acute seizure activity, such as status epilepticus. Its rapid action and ability to suppress the spread of seizure activity make it a preferred choice for emergency treatment. However, it is less effective for long-term seizure control compared to other benzodiazepines like clobazam, clonazepam, and clorazepate.
Pharmacokinetics[edit]
- Absorption: Diazepam is well-absorbed orally, reaching peak plasma concentrations within 1-2 hours.
- Distribution: It is highly lipophilic, allowing rapid penetration of the CNS.
- Metabolism: Metabolized in the liver by cytochrome P450 enzymes, primarily CYP3A4 and CYP2C19, into active metabolites such as desmethyldiazepam.
- Excretion: Excreted mainly via the kidneys in the form of conjugated metabolites.
Clinical Applications and Usage[edit]
FDA Approval and Indications[edit]
Diazepam was first approved by the Food and Drug Administration (FDA) in 1963 and remains widely used for various medical conditions, including:
- Anxiety disorders
- Acute muscle spasms
- Seizures, including status epilepticus
- Premedication for surgical or diagnostic procedures
- Management of alcohol withdrawal syndrome
Dosage and Administration[edit]
- For status epilepticus:
- Intravenous (IV) diazepam at 5-10 mg, repeated every 10-15 minutes if needed, up to a maximum of 30 mg.
- Premedication for anesthesia:
- Intramuscular (IM) diazepam at 10-20 mg.
Adjustments in dosage may be necessary for elderly individuals, patients with liver disease, or those taking other CNS depressants.
Safety and Monitoring[edit]
The long-term use of diazepam can lead to tolerance and dependence. Abrupt discontinuation may result in severe withdrawal symptoms, including agitation, tremors, and seizures. Tapering the dose under medical supervision is crucial to minimize withdrawal effects.
Side Effects and Drug Interactions[edit]
Side Effects[edit]
Common adverse effects of diazepam include:
- Somnolence (drowsiness)
- Confusion
- Dysarthria (difficulty speaking)
- Diplopia (double vision)
- Impaired coordination and coma in cases of overdose
In rare instances, diazepam may cause paradoxical reactions such as increased anxiety, agitation, or hallucinations.
Drug Interactions[edit]
Diazepam may interact with other medications, leading to enhanced sedation or altered drug efficacy:
- CNS depressants: Opioids, barbiturates, alcohol, and other benzodiazepines
- Enzyme inducers/inhibitors: Drugs that affect CYP3A4 activity can alter diazepam metabolism.
Patients should inform their healthcare provider of all medications, including over-the-counter and herbal products, to avoid adverse interactions.
Precautions[edit]
Diazepam should be used cautiously in:
- Elderly patients: Increased sensitivity to sedative effects
- Pregnant women: Risk of fetal benzodiazepine syndrome
- Individuals with a history of substance abuse: High risk of dependence
- Severe hepatic impairment: Risk of prolonged sedation and toxicity
Therapeutic Role and Limitations[edit]
Role in Epilepsy[edit]
Diazepam is primarily a short-term solution for acute seizure management. Chronic epilepsy is better managed with other antiepileptic drugs (AEDs) such as valproate, carbamazepine, or lamotrigine.
Psychiatric Applications[edit]
Diazepam's anxiolytic properties make it a choice for short-term management of severe anxiety. However, cognitive-behavioral therapy (CBT) is preferred for long-term anxiety management.
Limitations[edit]
Despite its effectiveness, diazepam has limitations:
- Dependency risk: Long-term use can lead to benzodiazepine dependence.
- Withdrawal challenges: Abrupt cessation can cause seizures or rebound anxiety.
- Tolerance: Over time, increasing doses may be needed to achieve the same therapeutic effect.
Future Directions[edit]
Research into GABAergic pathways and alternative benzodiazepine receptor modulators may pave the way for safer and more effective therapies.
| Medical uses | ||
|---|---|---|
|
| Pharmacodynamics | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Template:Glycine receptor modulators
|
Benzodiazipines[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
